Search research articles
Contact Us
Filters
Showing results (41-50 of 207) with videos related to
Page
of 21
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 10, 2019
<sup>111</sup>In-Pentetreotide Scintigraphy Versus <sup>68</sup>Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden
Thomas A Hope, Jeremie Calais, Li Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 3, 2018
Reply: Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way
Jeremie Calais, Wolfgang Peter Fendler, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 3, 2024
Dosimetry of [<sup>177</sup>Lu]Lu-PSMA-Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis
Zachary Ells, Tristan R Grogan, Johannes Czernin, et al.
Clinical Nuclear Medicine
|
May 15, 2020
PSMA Expression in the Neovasculature Associated With Rectal Adenocarcinoma: A Potential Stromal Target for Nuclear Theranostics
Ida Sonni, Justin Caron, Amar U Kishan, et al.
Frontiers in Oncology
|
September 5, 2025
Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer
Himisha Beltran, Jeremie Calais, Louise Emmett, et al.
BMC Cancer
|
January 9, 2019
Randomized prospective phase III trial of <sup>68</sup>Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
Jeremie Calais, Johannes Czernin, Wolfgang P Fendler, et al.
BMC Cancer
|
January 23, 2019
Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
Jeremie Calais, Johannes Czernin, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 15, 2023
PSMA-Negative Lesion Progression Under <sup>177</sup>Lu-PSMA Radioligand Therapy
Vishnu Murthy, Martin Allen-Auerbach, Richard Lam, et al.
Radiology. Imaging Cancer
|
June 18, 2026
Liver Background Uptake of Prostate-specific Membrane Antigen-targeted PET Radiotracers: A Systematic Review and Meta-Analysis
Gary A Ulaner, Ashwin S Parihar, Jeremie Calais, et al.
Nature Reviews. Urology
|
November 14, 2024
Molecular imaging of renal cell carcinomas: ready for prime time
Qianyun Wu, Hongda Shao, Wei Zhai, et al.
Page
of 21
Search research articles
Search
Showing results (41-50 of 207) with videos related to
Sort By:
Page
of 21
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 10, 2019
<sup>111</sup>In-Pentetreotide Scintigraphy Versus <sup>68</sup>Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden
Thomas A Hope, Jeremie Calais, Li Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 3, 2018
Reply: Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way
Jeremie Calais, Wolfgang Peter Fendler, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 3, 2024
Dosimetry of [<sup>177</sup>Lu]Lu-PSMA-Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis
Zachary Ells, Tristan R Grogan, Johannes Czernin, et al.
Clinical Nuclear Medicine
|
May 15, 2020
PSMA Expression in the Neovasculature Associated With Rectal Adenocarcinoma: A Potential Stromal Target for Nuclear Theranostics
Ida Sonni, Justin Caron, Amar U Kishan, et al.
Frontiers in Oncology
|
September 5, 2025
Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer
Himisha Beltran, Jeremie Calais, Louise Emmett, et al.
BMC Cancer
|
January 9, 2019
Randomized prospective phase III trial of <sup>68</sup>Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
Jeremie Calais, Johannes Czernin, Wolfgang P Fendler, et al.
BMC Cancer
|
January 23, 2019
Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
Jeremie Calais, Johannes Czernin, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 15, 2023
PSMA-Negative Lesion Progression Under <sup>177</sup>Lu-PSMA Radioligand Therapy
Vishnu Murthy, Martin Allen-Auerbach, Richard Lam, et al.
Radiology. Imaging Cancer
|
June 18, 2026
Liver Background Uptake of Prostate-specific Membrane Antigen-targeted PET Radiotracers: A Systematic Review and Meta-Analysis
Gary A Ulaner, Ashwin S Parihar, Jeremie Calais, et al.
Nature Reviews. Urology
|
November 14, 2024
Molecular imaging of renal cell carcinomas: ready for prime time
Qianyun Wu, Hongda Shao, Wei Zhai, et al.
Page
of 21